Floatz logo

Tavor

Bipolar Disorder

Dr. Stavroula RakitziPhase 4 / ApprovedActive
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
73/ 100

Competitive context

49 Active assets in the Bipolar Disorder cohort.

Asset / SponsorPhaseRating
Asenapine
Dr. Stavroula Rakitzi
Phase 4BBB
Cipralex
First Affiliated Hospital of Zhejiang University
Phase 4BBB
Seroquel®
First Affiliated Hospital of Zhejiang University
Phase 4BBB
Paroxetine
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Phase 4BBB
LITHIUM, ELEMENTAL
University of Aarhus
Phase 4BBB

View all 50 →

Same molecule, other indications

Tavor is also rated in:

bipolar disorderDormant
BB
Indicative ·
65 / 100
View asset →
treatment-refractory schizophreniaDormant
B
Indicative ·
62 / 100
View asset →
Obsessive-compulsive DisorderDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →